Medy-Tox Inc. | Mutual Funds
Mutual Funds that own Medy-Tox Inc.
FTIF SICAV - Templeton Asian Smaller Companies Fund
88,035
1.56%
-906
3.21%
06/30/2018
70,237
1.24%
-10,389
4.28%
03/31/2018
Government Pension Fund - Global (The)
63,887
1.12%
-28,135
0.01%
12/31/2017
Vanguard Total International Stock Index Fund
57,455
1.02%
2,206
0.01%
07/31/2018
Aberdeen Global - Asian Smaller Companies Fund
40,300
0.71%
-16,800
1.6%
05/31/2018
iShares Core MSCI Emerging Markets ETF
37,780
0.67%
0
0.05%
09/05/2018
Touchstone Sands Capital Emerging Markets Growth Fund
36,057
0.64%
-2,118
3.39%
06/30/2018
FTIF SICAV - Templeton Emerging Markets Smaller Companies
34,206
0.61%
0
2.06%
06/30/2018
Wasatch Emerging Markets Small Cap Fund
30,877
0.55%
0
3.27%
03/31/2018
Vanguard International Explorer Fund
29,935
0.53%
2,210
0.4%
06/30/2018
| Address |
78 Gangni 1-gil
Cheongju-si NC 28126
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.medy-tox.co.kr |
| Updated |
09/14/2018 |
| Medy-Tox, Inc. engages in the manufacture and sale of biopharmaceutical products. Its products include botulinum toxin, hyaluronic acid filler, medical devices, toxin detection kit and antitoxin therapeutics. The company was founded on May 2, 2000 and is headquartered in Cheongju-si, South Korea. |
